Editorji is a popular short video news and information platform based in India. It was founded in 2018 by Vikram Chandra, one of India’s leading journalists, and has risen to prominence in the digital news space in a relatively short span of time. The platform is primarily designed for mobile devices, with applications available for Android and iOS.

ABOUT US:

about us editorji

Latest Video News: Editorji provides the latest news video headlines, latest videos clip from India and the World. Get all breaking news videos on Entertainment, Business, Coronavirus, Elections, Politics and more.

Latest Video News, Breaking News, Bollywood, Political, Sports, Business News | Editorji

+91 11 4035 6666 / info@editorji.com
3rd floor, Plot B, Khasara no 360, Sultanpur, New Delhi, Delhi 110030
<a title="mail to us" href="mailto:info@editorji.com">Send Feedback</a>
<a title="Contact Us" href="mailto:info@editorji.com">Contact Us</a>

REACH US

Contact for any questions, suggestions, comments, feedback or advertisement on Editorji.com, we are always looking forward to hearing from you.

Contact Us for Feedback, Suggestions and Advertising 

Editorji content is better experienced in our app.

Vaccination passport: EU said its medical body has not received a request for the approval of Serum Insitute's Covishield for the ]Green Pass'

Travel concerns of vaccinated Indians: EU says not received Covishield approval request

Vaccination passport: EU said its medical body&nbsp;has not received a request for the approval of Serum Insitute's&nbsp;Covishield&nbsp;for the ]Green Pass'

EU Medical Body says not received Covishield approval request

Concerns after&nbsp;EU's 'Green Pass' Plan leaves out SII's&nbsp;Covishield
Covishield-vaccinated Indians facing issues with travel to Europe
SII&nbsp;chief Adar Poonawalla tweeted he had taken this up at the highest levels
EU: medical body hasn't received&nbsp;request for the approval of Covishield
EU: will examine any such request when received, as per its procedures
&nbsp;
&nbsp;

Vaccination passport: EU said its medical body&nbsp;has not received a request for the approval of Serum Insitute's&nbsp;Covishield&nbsp;for the ]Green Pass'

Amid concerns among Covishield-vaccinated Indians facing issues with travel to Europe, the EU said on Tuesday the medical body of the union, EMA has not received a request for the approval of Covishield&nbsp; in the COVID-19 'vaccination passport'. It will examine any such request when received, as per its procedures," the EU said in a statement.
The European Union has not yet recognised the India-made version of the AstraZeneca-Oxford University vaccine.
Serum Institute chief Adar Poonawalla tweeted that he had "taken this up at the highest levels, with regulators and at diplomatic levels" and that he hoped the matter would be resolved soon.
So far, only those vaccinated by either Pfizer, Moderna, AstraZeneca-Oxford and Johnson &amp; Johnson vaccines will be allowed restriction-free travel within the EU during the pandemic.
&nbsp;

Serum's manufacturing site will have to assessed for Covishield to get Green Pass appoval by EMA&nbsp;as per reports.&nbsp;The EMA&nbsp;said that approval for&nbsp;AstraZenca&nbsp;manufatcured&nbsp;Vaxzevria&nbsp;does not mean nod for Covishiel. In an email as reported by News18 EMA&nbsp;stated&nbsp;&ldquo;Even tiny differences in the manufacturing conditions can result in differences in the final product, and EU law therefore requires the manufacturing sites and production process to be assessed and approved as part of the authorisation process.&rdquo;However, the EMA&nbsp;also has clarified that the authority to issue or approve a green pass for travellers rests with the EU nation members but is linked with linked to EU marketing authorisation for vaccines which currently Serum's Covishield&nbsp;does not have.&nbsp;

Green Pass nod for AstraZenca does not mean the same for Serum: EMA

Green Pass route not so easy,&nbsp;EMA to assess Serum's manufacturing site&nbsp;

Serum pushes for Green Pass for Covishield 

Serum's manufacturing site will have to assessed for Covishield to get Green Pass approval by EMA&nbsp;as per reports.&nbsp;
The EMA&nbsp;said that approval for&nbsp;AstraZenca&nbsp;manufatcured&nbsp;Vaxzevria&nbsp;does not mean nod for Covishiel. In an email as reported by News18 EMA&nbsp;stated&nbsp;&ldquo;Even tiny differences in the manufacturing conditions can result in differences in the final product, and EU law therefore requires the manufacturing sites and production process to be assessed and approved as part of the authorisation process.&rdquo;
However, the EMA&nbsp;also has clarified that the authority to issue or approve a green pass for travellers rests with the EU nation members but is linked with linked to EU marketing authorisation for vaccines which currently Serum's Covishield&nbsp;does not have.&nbsp;

EMA to assess Serum's manufacturing site before giving approval needed for Green Pass.

Serum's manufacturing site will have to assessed for Covishield to get Green Pass approval by EMA&nbsp;as per reports.&nbsp; The EMA&nbsp;said that approval for&nbsp;AstraZenca&nbsp;manufatcured&nbsp;Vaxzevria&nbsp;does not mean nod for Covishield. In an email as reported by News18 EMA&nbsp;stated&nbsp;&ldquo;Even tiny differences in the manufacturing conditions can result in differences in the final product, and EU law therefore requires the manufacturing sites and production process to be assessed and approved as part of the authorisation process.&rdquo; However, the EMA&nbsp;also has clarified that the authority to issue or approve a green pass for travellers rests with the EU nation members but is linked with linked to EU marketing authorisation for vaccines which currently Serum's Covishield&nbsp;does not have.&nbsp;

ema

Categories